Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 3 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

1
Player Avatar rteberg (< 20) Submitted: 1/22/2013 7:22:21 PM : Outperform Start Price: $8.82 ARNA Score: -54.92

Weight loss drug will have great acceptance in the market

Featured Broker Partners


Advertisement